HomeFENC • NASDAQ
add
Fennec Pharmaceuticals Inc
Previous close
$6.15
Day range
$6.15 - $6.45
Year range
$4.68 - $9.92
Market cap
217.19M USD
Avg Volume
201.30K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 13.78M | 73.84% |
Operating expense | 14.57M | 77.86% |
Net income | -4.79M | -141.16% |
Net profit margin | -34.75 | -38.72% |
Earnings per share | -0.10 | -66.83% |
EBITDA | -2.53M | -178.11% |
Effective tax rate | -2.26% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 36.79M | 38.12% |
Total assets | 70.55M | 56.97% |
Total liabilities | 35.08M | -30.97% |
Total equity | 35.47M | — |
Shares outstanding | 34.48M | — |
Price to book | 5.91 | — |
Return on assets | -10.66% | — |
Return on capital | -25.36% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -4.79M | -141.16% |
Cash from operations | -5.96M | -304.48% |
Cash from investing | — | — |
Cash from financing | 20.80M | 270.35% |
Net change in cash | 14.84M | 208.44% |
Free cash flow | -4.77M | -327.96% |
About
Founded
1996
Headquarters
Website
Employees
35
